Free PDF: The Genius Workout — 50 brain teasers + the 25 highest IQs in history.
ブログ

Frances Oldham Kelsey:伝記、業績、そして不朽の遺産

Frances Kathleen Oldham Kelsey (née Oldham; July 24, 1914 – August 7, 2015) was a Canadian-American pharmacologist and physician who had a 45-year career with the U.S. Food and Drug Administration (FDA). As a reviewer, she refused to authorize thalidomide for market because she had concerns about the lack of evidence regarding the drug's safety. Her concerns proved to be justified when it was shown that thalidomide caused serious birth defects. Kelsey's career intersected with the passage of laws strengthening FDA oversight of pharmaceuticals. Kelsey was the first woman to receive a PhD in pharmacology and the second woman to receive the President's Award for Distinguished Federal Civilian Service, awarded to her by John F. Kennedy in 1962.

主な事実

遺産と影響

The influence of Frances Oldham Kelsey extends far beyond her own lifetime. She fundamentally shaped healthcare and human longevity, and her medical discoveries and treatments remain foundational to this day.

Though she passed away in 2015, her ideas continue to be studied, debated, and built upon by scholars and practitioners worldwide.

Frances Oldham KelseyはCanadaが生んだ最も称賛される頭脳の一人であり続け、地域の豊かな知的遺産を物語っている。

Canadaの著名な天才

Canadaは数多くの傑出した頭脳を輩出してきた。Frances Oldham Kelseyと並んで:

Canadaのすべての天才を見る →

Medicineの他の優れた頭脳を発見

探索 Medicine Geniuses

もっと見る

Frances Oldham Kelseyの完全なプロフィールを読む

Frances Oldham Kelseyのプロフィールを見る →

もっと天才を探す

1,300+ articles · 1,300+ biographies · 日本語

すべて見る